Stop Dying Early — Women
Women don’t die from what they have. Women die from what gets missed.
Woman, stop dying early.
Your symptoms were atypical. Your doctor said anxiety. Your labs came back normal. You knew something was off and had no language for it that anyone took seriously. I am a cardiologist. I have read the data. The data has a problem — and so does the system built on it.
The pattern I see — and the pattern the data missed
Women's cardiovascular disease presents differently, progresses differently, and is treated differently — with worse outcomes. Every link in that chain is peer-reviewed. This vertical exists to name it plainly.
The Invisible Presentation
Women's heart attacks look different. Fatigue, nausea, jaw pain — not the Hollywood chest-clutch. The missed diagnosis is not rare. It is the pattern.
The Hormonal Hinge
Oestrogen is cardioprotective until it isn't. Perimenopause, menopause, and the decade after are the highest-risk window most women are never told about.
The Silent Load
Chronic stress, emotional labour, and the physiology of always being the one who holds it together. The endothelium keeps score.
The Data Gap
Most cardiovascular trials excluded women until 1993. The guidelines you are being treated by were built on male bodies. This is what we actually know.
The clinical trials that built cardiology excluded women until 1993. The guidelines you are being treated by were built on male data.
This is not a complaint. It is a clinical fact with a body count. The same board-certified cardiologist who reads echocardiograms on Tuesday and publishes on Wednesday is now reading the women's data — and telling you exactly what it says, with honesty ratings on every claim.
Understand the SDE Honesty Index
SDE Honesty Index
Every clinical claim on this platform carries an evidence rating. The rating reflects the quality of the evidence behind the claim — not how confident it sounds. RCT-grade evidence earns a higher rating than a promising observation. The discipline separates clinical authority from wellness opinion.
RCT-grade evidence
Confirmed by randomised controlled trials or large prospective cohort studies with consistent replication.
Strong observational evidence
Supported by well-designed observational studies or meta-analyses. The association is consistent; the mechanism is plausible.
Emerging evidence
Early clinical or mechanistic data. Direction is consistent; replication is limited. Warranting attention, not yet practice-changing.
Mechanistic or theoretical basis
Biologically plausible based on known mechanisms. Limited or no direct human evidence. Presented as hypothesis, not conclusion.
Insufficient evidence
Claimed widely in health media without adequate clinical basis. Named here so the reader can weigh it correctly, not to endorse it.
The rating reflects what the evidence supports at the time of writing. Every rating is revisable as evidence develops. Dr. Job Mogire, MD, FACP, FACC · stopdyingearly.com
Explore the Women's section
Q&A Hub
Questions answered by a cardiologist
Deep Dives
Long-form clinical essays on women's cardiology
Articles
Clinical writing on female cardiovascular physiology
Signal Check
Women's cardiovascular risk assessment
Masterclass
10-module clinical curriculum on women's cardiovascular health
About
Dr. Job Mogire, MD, FACP, FACC
Start with the gap between how you feel and what your body is doing.
The Women's Signal Check is fifteen questions calibrated to female cardiovascular risk. It is the first clinical step.
Take the Women's Signal Check